Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
22,987
Total Claims
$899K
Drug Cost
480
Beneficiaries
$1,872
Cost/Patient
Risk Score Breakdown 31/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-60%
Opioid rate vs peers
1.0% vs 2.6% avg
+75%
Cost per patient vs peers
$1,872 vs $1,068 avg
+32%
Brand preference vs peers
11.8% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.0%
Opioid Rate
235
Opioid Claims
$6,757
Opioid Cost
17.4%
Long-Acting Rate
Brand vs Generic
Brand: 2,709 claims · $581K
Generic: 20,171 claims · $313K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 657 | $191K |
| Rivaroxaban | 104 | $35K |
| Empagliflozin | 25 | $21K |
| Mirabegron | 59 | $19K |
| Demeclocycline Hcl | 26 | $16K |
| Sacubitril/Valsartan | 15 | $16K |
| Insulin Lispro Protamin/Lispro | 20 | $15K |
| Umeclidinium Brm/Vilanterol Tr | 20 | $15K |
| Levothyroxine Sodium | 1,340 | $13K |
| Fluticasone Propion/Salmeterol | 31 | $13K |
| Dulaglutide | 12 | $12K |
| Memantine Hcl | 462 | $12K |
| Atorvastatin Calcium | 1,106 | $12K |
| Potassium Chloride | 758 | $11K |
| Gabapentin | 715 | $10K |
Prescribing Profile
Patient Profile
85
Avg Age
82%
Female
1.69
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About